Next Article in Journal
Underlying Conditions and Clinical Spectrum of Chronic Pulmonary Aspergillosis (CPA): An Experience from a Tertiary Care Hospital in Karachi, Pakistan
Next Article in Special Issue
Multicopper Oxidases in Saccharomyces cerevisiae and Human Pathogenic Fungi
Previous Article in Journal
Frequency of Invasive Fungal Disease in Adults: Experience of a Specialized Laboratory in Medellín, Colombia (2009–2015)
Previous Article in Special Issue
Applying the Host-Microbe Damage Response Framework to Candida Pathogenesis: Current and Prospective Strategies to Reduce Damage
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Phosphate in Virulence of Candida albicans and Candida glabrata

by
Julia R. Köhler
*,
Maikel Acosta-Zaldívar
and
Wanjun Qi
Division of Infectious Diseases, Boston Children’s Hospital/Harvard Medical School, Boston, MA 02115, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally.
J. Fungi 2020, 6(2), 40; https://doi.org/10.3390/jof6020040
Submission received: 4 March 2020 / Revised: 21 March 2020 / Accepted: 22 March 2020 / Published: 26 March 2020
(This article belongs to the Special Issue Pathogenesis of Candidiasis)

Abstract

:
Candida species are the most commonly isolated invasive human fungal pathogens. A role for phosphate acquisition in their growth, resistance against host immune cells, and tolerance of important antifungal medications is becoming apparent. Phosphorus is an essential element in vital components of the cell, including chromosomes and ribosomes. Producing the energy currency of the cell, ATP, requires abundant inorganic phosphate. A comparison of the network of regulators and effectors that controls phosphate acquisition and intracellular distribution, the PHO regulon, between the model yeast Saccharomyces cerevisiae, a plant saprobe, its evolutionarily close relative C. glabrata, and the more distantly related C. albicans, highlights the need to coordinate phosphate homeostasis with adenylate biosynthesis for ATP production. It also suggests that fungi that cope with phosphate starvation as they invade host tissues, may link phosphate acquisition to stress responses as an efficient mechanism of anticipatory regulation. Recent work indicates that connections among the PHO regulon, Target of Rapamycin Complex 1 signaling, oxidative stress management, and cell wall construction are based both in direct signaling links, and in the provision of phosphate for sufficient metabolic intermediates that are substrates in these processes. Fundamental differences in fungal and human phosphate homeostasis may offer novel drug targets.

1. Candida albicans is a Prevalent Human Commensal

This review focuses on the role of phosphate homeostasis in virulence of Candida albicans and C. glabrata, the most frequently isolated fungal species causing invasive disease in humans. Excellent reviews of the role of phosphate in virulence of other fungi have appeared [1,2] so we here focus on recent findings in Candida. C. albicans, the main focus of this review, colonizes oral and gastrointestinal mucous membranes in 40%–75% of healthy individuals [3,4,5]. It is thought to have co-evolved with its human host for millions of years [6]. But novel findings suggest that this species and its close relatives may have begun to colonize humans more recently than previously believed. It may be associated with plant environments overlooked by previous sampling efforts: recently it was isolated from bark of old-growth oak trees [7]. People in an Amazonian traditional community are rarely colonized by C. albicans [8]. One interpretation of these reports is that current highly prevalent human colonization states with C. albicans may have emerged during recent developments of human ecology like the rise of agriculture or industrialization. Nevertheless, whenever it was that C. albicans began its association with human mucous membranes, the subsequent large increase of its host population ensured its success as a commensal.

2. C. albicans Is Not a Highly Evolved Human Pathogen but It Can Exploit Host Weaknesses

C. albicans is not particularly well adapted as a human pathogen. Among the ascomycota, the phylum to which Candida belong, many species in the order Onygenales are professional pathogens with a life cycle that alternates between invasive disease of warm-blooded animals and proliferation in their victims’ cadavers and in the soil, from there producing infective propagules that can be inhaled to infect another animal. In contrast, overwhelming infection of the host is a dead end for Candida: It has no clear path from the soil back to its preferred niche, human mucous membranes. Until the last century, human populations susceptible to invasive candidiasis were vanishingly small. Still, C. albicans wields significant virulence factors that provide it access to host nutrient stores [9]. The ability to damage and digest host tissues and to withstand some host immune defenses, may have evolved to enable the fungus to spread via limited mucous membrane infections among the single human population naturally susceptible to C. albicans: Infants. In young infants, before development of anti-candidal adaptive immunity, thrush is common. Infants can spread sufficient inocula to their caregivers to maintain a large population of human hosts for Candida commensalism [10]. The virulence determinants honed by C. albicans against infants are sufficient to drive devastating invasive infections among today’s large immunocompromised patient populations, e.g., those undergoing chemotherapy or transplants, those requiring significant surgical interventions or depending on long-term indwelling lines like dialysis- and parenteral nutrition-dependent patients.

3. Phosphate is Indispensable for C. albicans Growth, a Precondition for its Pathogenesis

Candida species are among the majority of pathogens that, unlike e.g., Clostridium tetani, can only cause disease if they grow and replicate for many generations. During growth in human tissues, Candida cells must withstand host environmental conditions very unlike their growth optima: Temperatures ≥36 °C, nutrient deprivation especially for glucose and phosphate, microaerophilic or anaerobic environments, and pH 7.35–7.45 [11]. They must additionally resist host immune cells like neutrophils and macrophages that actively deploy oxidative, nitrosative and cationic stressors, as well as cell wall stress [12]. Phosphate is critical for Candida cells to grow, replicate and withstand host-imposed stress during invasive disease.
Phosphorus is an essential element for all cells as an abundant component of macromolecules. Without sufficient phosphate there is no cellular growth because ribosomal RNA, mRNAs, and tRNA cannot be synthesized and phospholipid membranes cannot be expanded. There is also no cell division, because DNA cannot be replicated. More fundamentally, there is no energy production: Initiation of glycolysis requires two phosphate moieties per glucose molecule, and oxidative phosphorylation depends on phosphate repletion in the mitochondrial matrix [13]. In the model yeast Saccharomyces cerevisiae, the mitochondrial membrane potential itself requires phosphate transport into the matrix [14].

4. Phosphate Acquisition Differs Fundamentally between Organisms That Ingest Food, and Those That Absorb It

Phosphate acquisition and homeostasis inevitably are core components of all cells’ regulatory systems. But the regulatory needs of absorbing organisms differ fundamentally from those that ingest their food. Organisms like amoebae and animals, that obtain their nutrition by ingesting cells, will concomitantly acquire ample phosphate together with the nitrogen- and carbon sources of which these cells are composed. In contrast, organisms that absorb their nutrients, often after extracellular digestion by secreted enzymes, like bacteria, fungi, and plants, must import phosphate against a steep concentration gradient [15]. For this reason, phosphate homeostatic systems of the latter group of organisms have many similarities despite the large evolutionary distances between them.
Phosphate homeostatic systems of bacteria and fungi, i.e. absorbing organisms, include plasma membrane phosphate transporters, phosphate sensors that may be extra- or intracellular, mechanisms to store surplus as polyphosphate, and regulatory systems including a central transcription factor to maintain phosphate repletion without intoxicating the cytoplasm with orthophosphate. These systems are called the PHO regulon and have been studied extensively in bacteria [16] and in S. cerevisiae [17,18,19]. In pathogenic bacteria, phosphate acquisition is known to be crucial in virulence [20,21,22]. A recent superb review compares the S. cerevisiae PHO regulon with those of its elements known to be conserved in C. albicans and other human fungal pathogens [1]. The activity of many of these elements is only beginning to be characterized, and novel components remain to be discovered, but in broad strokes, the PHO regulon of these fungi resembles that of S. cerevisiae [23].

5. Recognizing a Role of Phosphate in C. albicans Virulence

The role of phosphate homeostasis in C. albicans pathogenesis was first recognized by the Aberdeen Fungal Group who characterized and quantified virulence phenotypes of 43 clinical C. albicans isolates representing 4 known clades [24]. They correlated expression profiles among a subset of these strains, 5 from each clade, with virulence phenotypes. Five among 18 genes differentially expressed in isolates displaying differing virulence were found to function in phosphate homeostasis: The genes encoding plasma membrane transporters Pho84, Pho87, and Git1, the polyphosphate synthetic enzyme subunit Vtc4, and the acid phosphatase Pho100. Deletion of PHO100 led to modest attenuation in virulence [24]; Pho100 is one of at least 3 acid phosphatases annotated in the Candida Genome Database [25].
Expression profiling of C. albicans in various in vitro, ex vivo and in vivo infection models consistently showed induction of PHO84, encoding the major high affinity proton–phosphate symporter; PHO89, which encodes a homolog of a high affinity S. cerevisiae sodium–phosphate transporter with an alkaline optimum, was also upregulated in some models [26,27,28,29,30,31]. Though these studies did not take particular note of PHO regulon components’ role in C. albicans interactions with the host, induction of the high-affinity phosphate transporters across a variety of infection models highlights the importance of phosphate acquisition during infection.

6. The Transcriptional Regulator that Controls Phosphate Homeostasis is Required for C. albicans Stress Resistance

A requirement for the PHO regulon transcriptional regulator, Pho4, in C. albicans resistance to numerous stressors was then identified in two simultaneously published screens [32,33] of two transcription factor mutant sets [34,35]. Notably, very few other transcription factors were required in multiple of these diverse forms of stress. The stressors to which pho4 null mutant cells were hypersensitive include 2 M sorbitol (osmotic stress), 1 M NaCl and 0.6 M KCl (osmotic and cationic stress), 10 mM MnCl2, 5 mM FeCl2, 450 mM CaCl2, 2 mM NaAsO2, or 0.32 μg/mL spermidine (metal, inorganic and organic cationic stress), 5 and 10 mM H2O2 (peroxide stress), 150 and 300 uM menadione (superoxide stress), 0.6 mM S-Nitroso-L-glutathione (nitrosative stress) and pH 8 (alkaline stress) [32,33]. Pho4 was also shown to be involved in resistance to arsenic stress (an oxidative stress-inducing toxic metal taken up by phosphate transporters) [36,37]. Cells lacking Pho4 were hypersensitive to 20% serum and defective in hyphal growth in response to serum as well as in response to phagocytosis by macrophages [33]. Their survival after macrophage phagocytosis, and their ability to kill macrophages, was diminished compared to wild type [33]. In two in vivo infection models, pho4 null mutant cells showed attenuated virulence: Caenorhabditis elegans that ingested pho4 null mutant cells survived significantly longer than those fed wild type or re-integrant cells; and in a murine intravenous infection model, the outcome score (a combination of kidney fungal burden and weight loss at 3 days after infection) was significantly decreased for pho4 null mutants [33]. In addition to the unequivocal virulence defects shown in infection models [33], a fitness defect of pho4 null mutant cells was identified in a mouse intestine commensalism model [32]. These studies converged on the conclusion that Pho4 regulates processes by which C. albicans withstands a broad variety of stressors that impact the fungus during invasive disease and during commensalism.
Ikeh et al. examined which stressors induced nuclear localization of Pho4, corresponding to its active state [33]. They found that only phosphate starvation and alkaline stress, but not cationic or superoxide stress have this activating effect on Pho4 [33]. They then used reverse-transcribed RNA sequencing (RNA-Seq) to identify Pho4-controlled genes [33]. The results highlighted similarities and differences between the role of Pho4 in C. albicans and S. cerevisiae. A striking difference is that the number of C. albicans Pho4-regulated genes at >130 [33] is far larger than the 22 found for S. cerevisiae Pho4 using microarrays [38]. Similar to S. cerevisiae, Pho4 was found to upregulate a core set of genes involved in acquisition and storage of phosphate: the gene encoding the high-affinity phosphate transporter Pho84, transporters of glycerophosphodiesters Git1, -2, and -3, and a glycerophosphocholine phosphodiesterase Gde1. Also Pho4-regulated were several acid phosphatases (Pho100, Pho112, and Pho113) that liberate phosphate from organic compounds to make it accessible to absorption [33,39]. Additionally, genes encoding enzymes that participate in polyphosphate synthesis at the vacuolar membrane, Vtc1 and Vtc3, were found to be Pho4-induced [33]; polyphosphate is a storage polymer synthesized by vacuolar transporter chaperone (VTC) complex components Vtc1–4 [33].
The transcriptional analysis did not reveal an obvious mechanism by which Pho4 contributes to C. albicans stress resistance [33]. In phosphate-rich media, Pho4 normally is inactivated by phosphorylation and exits the nucleus. Intriguingly, some genes related to oxidative stress were expressed to abnormally high levels in pho4 null mutant cells growing in phosphate rich medium: Those encoding copper-requiring superoxide dismutase enzymes Sod1, -5, and -6 [33]. This finding suggests that in wild type cells, Pho4 contributes to repression of these genes in phosphate-replete conditions, perhaps because in these conditions, cells can more readily access other mechanisms of superoxide detoxification. However, expression of SOD3, which encodes a fungal manganese-dependent cytosolic superoxide dismutase, and enzymatic activity of Sod1, a copper-dependent cytosolic superoxide dismutase, were decreased in pho4 null mutant cells [33]. This was apparently due to decreased bioavailability of copper (whose total stores were not decreased in pho4 cells), possibly because CRD2, encoding a copper metallothionein, was overexpressed in cells without Pho4 [33].
Two other metals were depleted in pho4 mutant cells: they had only about 16% of the manganese and ~30% of the magnesium content of wild-type cells [33], possibly because they lacked polyphosphate as a metal chelator [33]. However, other cationic metals were not decreased in these cells [33]. Nevertheless, the metal imbalance could disturb the function of superoxide dismutases like Sod3 that require manganese [40]. Hence the contribution of the Pho4 transcriptional regulator to stress responses may be related to metal homeostasis. pho4 mutant cells contain only ~40% of wild type cell total phosphate [33]. Lack of phosphate itself could perturb stress-buffering functions, as discussed further below.

7. Comparison of Pho4-Regulated Genes in Two Closely Related Yeasts, a Plant Saprobe and An Opportunistic Human Pathogen

Is the difference noted by Ikeh et al. [33], between the large C. albicans Pho4-regulated gene set and the limited PHO regulon of S. cerevisiae simply a consequence of their long evolutionary separation, is it an adaptation to the different conditions to which S. cerevisiae versus C. albicans are exposed, or both? Several groups took an ingenious approach to this question by comparing the Pho4-regulated genes of the closely related yeasts S. cerevisiae and Candida glabrata, another human-adapted yeast. Among adult patients, C. glabrata is now the second most frequently isolated invasive fungal pathogen [41], given selection pressure by widespread use of azole antifungal agents (to which C. glabrata is more resistant) among this patient population. This yeast shared a common ancestor with the plant saprobe S. cerevisiae only 10 million years ago and its proteins display ~75% sequence identity with those of S. cerevisiae [42]. Hence C. glabrata provides an interesting comparison of PHO regulon functions required in the lifecycle of a human commensal and pathogen, with those of plant-associated S. cerevisiae, that thrives on damaged fruit and persists in oak bark and leaf litter [43].
During S. cerevisiae cells’ response to phosphate starvation, Pho4 cooperates with another transcriptional regulator, Pho2, to control ~20 target genes [18,44,45]. Pho2 also partners with another transcription factor, Bas1, to activate genes not regulated by Pho4: Those encoding components of purine nucleotide biosynthesis that utilize the phosphate-rich intermediate phosphoribosyl pyrophosphate (PRPP); PRPP is also a substrate in pyrimidine and histidine biosynthesis [46]. C. glabrata Pho4 can activate transcription of most of its targets independently of cooperation with Pho2 [42,45]. The C. glabrata Pho4 protein is larger, comprising 533 amino acids as opposed to S. cerevisiae Pho4′s 313 amino acids and it regulates more genes than the S. cerevisiae ortholog [42,45]. Genes controlled by S. cerevisiae Pho4 are essentially all involved in the response to phosphate starvation and in intracellular phosphate distribution [38,44,45]. In contrast, C. glabrata Pho4 activates 79 genes, only 16 (~20%) of which function in phosphate homeostasis [45]. C. glabrata Pho4 Gene Ontology (GO) term searches for the other genes showed ~25% linked to “response to stress or chemical”, and 10% involved in “cell wall organization” [45]. Comparing Pho4-regulated genes in yeast species of distinct phylogenetic distances to C. glabrata and S. cerevisiae, with Pho4 dependence on Pho2 cooperation, the authors concluded that expansion of gene networks regulated by Pho4 correlates with its independence from Pho2 [45].
We speculate that perhaps, a single transcriptional regulator can more tightly coordinate between phosphate homeostasis and stress responses than two cooperating transcription factors. This close co-regulation could conceivably be more important for a commensal and pathogen subjected to defensive stressors by the host (from which it seeks to obtain phosphate), than for a saprotrophic yeast. Invasion of a host seems to evoke transcriptional signatures of phosphate starvation in the fungus [26,27,28,29,30,31], while dependably inducing the host to impose oxidative stress on its cells. Hence in an instance of anticipatory regulation [47], an opportunistic pathogen like C. glabrata may have ensured that stress responses occur promptly during host invasion by tying them to phosphate starvation responses with the same transcription factor, Pho4.
Further comparisons among fungal clades were drawn by Lev and Djordjevic who analyzed published data on genome-wide transcriptional analyses of genes controlled by Pho4 in 4 fungal species, the ascomycetes S. cerevisiae [38] with its close relative C. glabrata [45] and C. albicans [33], and the basidiomycete Cryptocccus neoformans [2]. As noted above, in S. cerevisiae, Pho4′s control of phosphate starvation-modulated genes requires cooperation with Pho2, unlike in the other species, while in C. neoformans, no Pho2 ortholog is known. These authors categorized the genes controlled by Pho4 in the human pathogens using GO terms: Genes involved in transport, lipid- and carbohydrate metabolism [2]. Additionally, in the ascomycete pathogens C. glabrata [45] and C albicans, but not in the basidiomycete C. neoformans, Pho4 controls genes involved in responses to stress, to chemicals and to drugs.

8. Cooperation of Transcriptional Regulators, Versus Control by a Single Transcription Factor, as Strategies to Coordinate Genes Required for ATP Biosynthesis

Another functional connection appears to emerge between genes regulated by Pho4 in C. glabrata and C. albicans, in which Pho4-Pho2 cooperation is diminished or absent as compared with S. cerevisiae, and genes regulated independently by Pho2 homologs. As mentioned, S. cerevisiae Pho2 (also called Bas2) controls expression of enzymes that yield adenylate, i.e., enzymes in purine and histidine biosynthesis [46], which proceeds from PRPP, a donor of high-energy phosphate groups. Hence in S. cerevisiae, cooperation between the 2 transcriptional regulators Pho4 and Pho2 coordinates provision of inorganic phosphate for PRPP synthesis, with purine biosynthesis [48,49], to facilitate production of the central energy- and phosphate donor of the cell, ATP. In C. albicans, Pho4 alone assumes some of this coordination, e.g., the gene encoding adenylate kinase, ADK1 (controlled by Pho2 in S. cerevisiae), is controlled by C. albicans Pho4 [33]. In this way, the shift between the Pho2-, Pho4-Pho2- and Pho4- regulated genes in the saprobe compared with the human pathogens, extends to genes required to supply the metabolic precursors for ATP.
Interestingly, in addition to controlling adenylate biosynthesis genes, thereby enabling ATP production, the C. albicans Pho2 ortholog Grf10 contributes to hyphal growth and virulence [50,51]. We conjecture that given the central roles of adenine-based nucleotides in energy provision, metabolic enzyme cofactor synthesis, enzyme regulation through post-translational modification, second messenger production, and signaling [52], disturbed ATP production leads to wide-ranging disruption of essential functions in the cell.

9. The PHO Regulon Controls Transporters of Organic and Inorganic Phosphate Compounds

In C. albicans, Pho4 controls expression of plasma membrane transporters of phosphate-containing molecules derived from plasma membrane phospholipids (glycerophosphodiesters), Git1–4 [53,54]. Comparison of these proteins with their S. cerevisiae orthologs showed an expanded gene family of glycerophosphocholine transporters in C. albicans [54]. GIT2, 3 and 4 are aligned in tandem on chromosome 5 [54]. Git3 and to a lesser extent Git4 have important roles in uptake of glycerophosphocholine [54] while the role of Git2 has not been elucidated. C. albicans cells in which the entire region encoding Git2, -3, and -4 was deleted are attenuated in virulence [54], highlighting the importance of glycerophosphocholine as a phosphate source during the interaction with the host. This work also found that the cytoplasmic Gde1 glycerophosphodiesterase makes a major contribution to use of glycerophosphocholine as the sole phosphate source, presumably by hydrolyzing the ester and liberating inorganic phosphate [54]. In the same study, a C. albicans pho4 mutant failed to upregulate GIT3, GIT4, or GDE1 in response to low ambient phosphate conditions, confirming that these genes are under the control of Pho4 [54]. Figure 1 shows a cartoon of the C. albicans PHO regulon components discussed here.
As noted, C. albicans PHO4 is required for resistance to alkaline stress [33]. Alkaline conditions, unlike oxidative stress, by themselves induce activation of C. albicans Pho4, as determined from its localization to the nucleus [33]. Since multiple homeostatic mechanisms maintain the pH of human blood and tissues between 7.35 and 7.45, C. albicans undergoes alkaline stress during invasive disease. Lev and Djordjevic argue that in the host, alkaline stress causes phosphate starvation responses despite inorganic phosphate concentrations in the 1–2 mM range, because the major high-affinity phosphate–proton symporter Pho84 requires a proton gradient across the fungal plasma membrane [2]. Given its mechanism of phosphate transport, by which protonation of a conserved amino acid in the transmembrane channel (Asp358 in S. cerevisiae [55]) is a condition for a conformational change that enables phosphate transport [55], this rationale seems highly plausible. Interestingly, the other known phosphate transporters in C. albicans appear unable to provide sufficient phosphate in alkaline pH and moderate phosphate concentrations: Pho89 is a high-affinity transporter with an alkaline optimum in S. cerevisiae and in that organism is controlled by the stress responsive calcineurin-dependent transcription factor Crz1, not by Pho4/Pho2 [56]. The C. albicans genome encodes homologs of at least 2 other S. cerevisiae low-affinity phosphate transporters that are active in high ambient phosphate, Pho87 and Pho90 [25,57].
We speculate that, as in other fungi like S. cerevisiae, Pho84 is the critical plasma membrane transporter in C. albicans and can be only partially substituted by Pho89 and the low-affinity transporters, because the fungus is not fully adapted to conditions prevailing during invasive disease in the host. In line with the rationale proposed by Lev and Djordjevic [2], alkaline hypersensitivity of the pho4 null mutant analyzed by Ikeh et al. [33] may therefore be attributable to these cells’ impaired PHO84 expression. The circumstances that C. albicans apparently relies on a phosphate–proton symporter whose pH optimum is 4–5, not on the Na+-phosphate symporter Pho89 (which has an alkaline optimum), while the pH of healthy human tissue and blood induces alkaline stress, suggest that invasive candidiasis is an accidental incursion for which the fungus is evolutionarily ill-prepared.

10. A Pho84 Function Activates C. albicans TORC1, and TORC1 Modulates the PHO Regulon

A first characterization of C. albicans Pho84 was undertaken when its role in activating signaling of Target of Rapamycin Complex 1 (TORC1) was identified in a screen for rapamycin hypersensitive C. albicans mariner transposon mutants [15]. TORC1 signaling activity was found to depend both on the phosphate availability in ambient media, and on the presence of Pho84, which appears to signal to TORC1 through the upstream small GTPase Gtr1 [15]. In S. cerevisiae, Pho84 is known to have a signaling role to protein kinase A (PKA) that is genetically and chemically separable from its phosphate transport activity [55,58,59,60]; whether in C. albicans, Pho84 has such a “transceptor” [55,59,61] role towards PKA or TORC1 remains to be experimentally established. TORC1 integrates eukaryotic cells’ responses to nutrient availability and absence or presence of stressors as the major regulatory module, inducing growth and proliferation in favorable conditions of ample nutrients and absent stress, or growth arrest and stress responses during starvation and stress exposure [62,63,64]. Classically, TORC1 is known to respond to nitrogen sources [65] and this has been experimentally determined to be true in C. albicans as well [66]. It was shown that phosphate availability is integrated into the TORC1 signal of C. albicans and S. cerevisiae [15]: an unsurprising finding given that phosphate is a critical component of large cellular structures like chromosomes, ribosomes, mRNA and membranes, and nitrogen and carbon source repletion is not adequate for anabolic processes like DNA replication or ribosome biogenesis in the absence of sufficient phosphate [67].
TORC1 co-regulates expression of genes required for nitrogen source acquisition like the ammonium transporter Mep2 during nitrogen-starvation versus -refeeding [68]. A role for the Tor1 kinase was also shown in phosphate acquisition, for downmodulating PHO84 expression during phosphate refeeding [15]. Similarly, TORC1 artificially activated by ectopic GTR1 overexpression downregulates secreted acid phosphatase during phosphate starvation that is normally induced by the PHO regulon [15]. TORC1 signaling therefore acts on the PHO regulon to fine-tune the fungal cell’s resource expenditures on proteins deployed for phosphate acquisition.
Intact C. albicans TORC1 signaling regulates morphogenesis and other cellular processes that are active during infection [69,70]. The potent C. albicans TORC1 inhibitor rapamycin is cidal for the fungus [71,72]. Rapamycin is unsuitable as an antifungal agent because it is also highly active against human TORC1, resulting in immunosuppression at low doses and multiple toxicities at higher ones [73,74]. For this reason, it was considered that inhibiting Pho84, which has no human homolog, might be an indirect, nontoxic route to inhibiting C. albicans TORC1 [15]. Small molecules phosphonoacetic acid and phosphonoformic acid (foscarnet), an antiviral agent in clinical use, inhibit Pho84 in S. cerevisiae [59] and C. albicans and induce downregulation of TORC1 signaling [15]. They also potentiate the antifungal activity of amphotericin B and micafungin against wild type C. albicans, recapitulating the hypersensitivity phenotypes of pho84 mutant cells against these drugs [15]. Amphotericin and micafungin represent 2 major classes of antifungal agents, the polyenes and echinocandins. Foscarnet itself has significant toxicities but as a proof of concept can inspire the search for other Pho84 inhibitors with fewer off-target effects, which could potentiate these antifungal agents.

11. Defects in Virulence and Oxidative Stress Resistance of Cells Lacking Pho84

Cells lacking Pho84 show virulence attenuation in murine and Drosophila models of infection [75]. These cells are defective in hyphal growth and hypersensitive to killing by human whole blood and by neutrophils [75]. Releasing superoxide anion in the oxidative burst is a major antimicrobial killing mechanism of neutrophils; pho84 null mutant cells were not hypersensitive to neutrophils from a patient with chronic granulomatous disease which lack the capacity to generate an oxidative burst [75]. Accordingly cells lacking Pho84 poorly tolerate pharmacologic superoxide generators compared to wild type [75]. Measurement of intracellular reactive oxygen species (ROS) showed that both during extrinsic oxidative stress, and in unstressed normal growth conditions, pho84 null mutant cells contain more ROS than wild type [75]. A major signaling system that activates survival responses to oxidative stress, the HOG pathway, is hyperactive in pho84 null mutant cells exposed to peroxide; hence a defect not in signaling, but in the execution of oxidative stress management systems is apparently responsible for the accumulation of ROS and hypersensitivity to extrinsic oxidative stress shown by pho84 null mutant cells [75].
Polyphosphate acts as an antioxidant in other organisms [76]. In S. cerevisiae, it is synthesized on the vacuolar membrane and translocated into the vacuolar lumen by the vacuolar transport complex (VTC) whose catalytic subunit Vtc4, transfers the gamma phosphate of ATP onto a growing phosphate anhydride chain [77,78]. It was considered that C. albicans cells defective in phosphate acquisition might be hypersensitive to oxidative stress because they lack an antioxidant activity of polyphosphate [33]. However, Ikeh et al. did not find hypersensitivity to stressors, including superoxide stress, in C. albicans mutants lacking the catalytic (Vtc4) or a regulatory component (Vtc1) of the VTC [33]. Hence a potential contribution of polyphosphate to oxidative stress management in C. albicans remains undefined.
Expression of the unique manganese-containing cytosolic superoxide dismutase, Sod3 [40,79], is low at the mRNA level in pho4 mutants [33], as it is at the protein level in pho84 null mutant cells [75]. These findings are mutually consistent because PHO84 expression depends on Pho4 activity [33], so that cells without Pho4 are expected to show phenotypes corresponding to lack of Pho84. Sod3 expression was found to represent a link between Pho84 and TORC1: Cells lacking Pho84, in which TORC1 is artificially activated by GTR1 overexpression, recover Sod3 expression and their intracellular ROS increase is largely rescued [75]. Conversely, overexpression of SOD3 from a heterologous promoter significantly—but not completely—rescues oxidative stress hypersensitivity of pho84 null mutant cells [75]. Neither GTR1 nor SOD3 overexpression rescues pho84 null mutant cells’ hypersensitivity to whole blood and neutrophils, though, indicating that defective TORC1 signaling and subsequent low Sod3 levels are one, but not the only mechanism of these cells’ hypersensitivity to ex vivo host defense models [75].

12. Cell Wall Stress Hypersensitivity of C. albicans Cells Lacking Pho84

What other molecular alterations in pho84 null mutant cells are responsible for their hypersensitivity to host immune mechanisms? Another possible weakness of these cells is their defective cell wall [80]. Their outer phosphomannan cell wall layer is thinner, they contain less chitin and beta-1,6-glucan, and they are hypersensitive to cell wall stress [80]. The cell wall stressors to which cells lacking Pho84 are susceptible are varied and include beta-1,3-glucan synthase inhibition by the echinocandin micafungin, chitin synthase inhibition by nikkomycin, heat, and disruption of chitin-glucan bonds by Congo red [80]. Hypersensitivity of C. albicans wild type and pho84 null mutant cells to pharmacologic cell wall stressors is inversely related to their phosphate repletion state [80]. This hypersensitivity corresponds to deficient cell wall stress signaling as assayed by the phosphorylation state of the cell wall integrity pathway MAP kinase Mkc1 [80]. Mechanical weakness of the cell wall might contribute to pho84 null mutant cells’ inability to withstand neutrophil hydrolytic enzymes [81]. Cell wall integrity defects of pho84 null mutant cells cannot be rescued by artificial TORC1 activation [80], suggesting they may be independent of these cells’ TORC1 signaling perturbation.

13. pho84 Null Mutant Cells Lack Nucleotide Sugars, Substrates of Cell Wall Biosynthetic Enzymes

Metabolomics experiments intimated how lack of C. albicans Pho84 could result in cell wall defects. The substrates of biosynthetic enzymes that produce the major structural cell wall polysaccharides, beta-1,3- and beta-1,6-glucan and chitin, are the nucleotide sugars uridine-diphosphate (UDP)-glucose and UDP-N-Acetylglucosamine, respectively. Both these substrates, as well as their phosphoric precursor uridine-triphosphate (UTP), were significantly diminished in pho84 null mutant cells recovering from phosphate starvation, compared with wild type cells [80]. Similarly, GTP, a precursor in the production of GDP-mannose required in cell wall phosphomannan biosynthesis, was drastically diminished in these cells, as were the other nucleotides including ATP [80]. Strikingly, in nucleotide and nucleotide sugar biosynthetic pathways, the intermediates before a phosphorylation step accumulated, while those after it were diminished in cells lacking Pho84 [80]. This finding suggests that lack of the phosphate provided by ATP also slows the reaction rate of kinases in pyrimidine and purine nucleotide synthesis [80]. The result is that substrate concentrations for beta-1,3- and beta-1,6-glucan synthases, as well as for chitin synthases, are low in cells lacking Pho84 [80]. The polysaccharide products of these enzymes provide the structural stability and the shape of the cell wall.
Lack of Pho84 potentiated C. albicans growth inhibition arising from pharmacologic or genetic perturbation of glucan and chitin synthase activity [80]. It also blocked normal compensatory stimulation of chitin production when beta-1,6-glucan synthase is genetically depleted [80,82]. A simple model emerges from these findings: lack of their nucleotide sugar substrates slows the reaction rate of enzymes that synthesize cell wall polysaccharides in cells without Pho84, leading to a dearth of cell wall structural stabilizers and a weakened cell wall. Potentiation of micafungin, a beta-1,3-glucan synthase inhibitor, by the Pho84 inhibitor foscarnet may presage an antifungal combination in which cell wall biosynthesis is inhibited at 2 successive steps, at nucleotide sugar biosynthesis and at glucan or chitin synthesis. A paradigm for deploying inhibitors of successive steps in a crucial microbial biosynthetic process to potentiate the effect of each, is inhibition of tetrahydrofolate biosynthesis by the combination of trimethoprim with sulfamethoxazole (Bactrim or Cotrimoxazole), an antibiotic that is still essential after >4 decades [83]. Perhaps this paradigm could also be applied successfully in antifungal development.

14. Lack of ATP Impacts C. albicans Carbon Metabolism

Other critical pathways in central metabolism are significantly affected by lack of C. albicans Pho84: glycolysis, the citrate (TCA) cycle, and the pentose phosphate pathway [80]. Given the need for 2 molecules of ATP for every glucose molecule in the preparatory phase of glycolysis, and the utilization of an inorganic phosphate in the 6th reaction of glycolysis [52], slowing of glycolysis in conditions of low ATP and low free cytosolic phosphate that prevail in pho84 null mutant cells [15] seems intuitive. Inorganic phosphate is needed to generate ATP, whether in the cytosol or in the mitochondrial matrix where it is a required substrate of ATP synthase; the essential role of mitochondrial phosphate import was recently shown when a novel antifungal agent was characterized whose fungicidal activity occurs through blocking a mitochondrial phosphate pump [84]. Similarly, lack of inorganic phosphate in the mitochondrial matrix might impede generation of ATP by oxidative phosphorylation. In fact, NADH, the electron carrier at the entry point into oxidative phosphorylation, is elevated in pho84 null mutant cells compared to wild type, while its oxidized redox partner NAD is depleted [80], suggesting a block in a major cellular consumption point of NADH, oxidative phosphorylation.
Lack of ATP may introduce further inefficiencies of carbon catabolism, by impeding biosynthesis of coenzyme A [85] which is required for entry of 2-carbon units into the citric acid cycle and is decreased in pho84 null mutant cells [80], or by slowing entry into the pentose phosphate pathway through diminished glucose phosphorylation, as these cells contain less ribose-phosphate [80].
Hence to generate ATP, both inorganic phosphate, and the energy from oxidation of carbon sources to create the third, high-energy phosphate bond are necessary. To utilize these carbon sources, upfront investment of ATP is required to channel carbon sources into glycolysis, the pentose phosphate cycle, and the citric acid cycle. We speculate that lack of phosphate may feed forward to further impede ATP synthesis, when the fungal cell is unable to utilize the energy potential of its carbon sources because the upfront investment cannot be made.

15. Metabolites with Roles in Oxidative Stress Management are Decreased in C. albicans Cells Lacking Pho84

Whether phosphate starvation-related inefficiency of oxidative phosphorylation in cells lacking Pho84 increases the constitutive generation of ROS during this process [52] needs to be experimentally tested. However, compounds that participate in detoxifying ROS in other species, are diminished in these cells [80]: thiamine pyrophosphate [86] and ascorbic acid [87].
Purine metabolism, which is disrupted in pho84 null mutant cells, is one of the pathways leading into thiamine pyrophosphate biosynthesis. Thiamine when added exogenously protected E. coli against intracellular superoxide anions induced by paraquat, and it diminished induction of oxidative stress response genes [88]. These authors speculated that thiamine might act as a direct scavenger of superoxide anions [88]. Biosynthetic enzymes of this coenzyme are induced during oxidative stress in S. cerevisiae in connection with Hog1 and Yap1 [86] while exogenous administration of thiamine protects S. cerevisiae cells exposed to peroxide stress [89]. A role of thiamine in C. albicans stress responses has not yet been examined.
In addition to being the substrate of beta-1,3- and beta-1,6- glucan synthases, the nucleotide sugar UDP-glucose is a precursor in the biosynthesis of erythro-ascorbic acid, an analog of Vitamin C synthesized by S. cerevisiae and C. albicans [87,90]. Presumably it is erythro-ascorbic acid whose LC-MS/MS profile in C. albicans metabolome extracts was interpreted as ascorbic acid, and whose content was drastically reduced in pho84 null mutant cells recovering from phosphate starvation in excess phosphate [80]. The significantly diminished UDP-glucose content of cells lacking Pho84 may therefore determine not only their cell wall integrity defects, but also affect their ability to produce erythro-ascorbic acid as a reducing agent in managing intracellular ROS [87,90]. C. albicans cells engineered to lack the final enzyme in the erythro-ascorbic acid biosynthetic pathway are defective in hyphal growth and attenuated in virulence in an intravenous mouse infection model [90]; these investigators surmised that erythro-ascorbic acid may be an important antioxidant in the host interaction to enhance survival of the fungus during host-imposed oxidative stress [90]. Figure 2 shows a selection of the Pho84-connected processes that contribute to tolerance of oxidative stress and cell wall stress in C. albicans.

16. Perturbation of Phosphate Homeostasis may be Clinically Useful

Given the essential role of phosphate in all core processes of the cell, pharmacologically inhibiting its acquisition might impact growth and virulence of Candida species in therapeutically useful ways. A critical advantage of phosphate homeostasis as a drug target is that this process shows 2 fundamental differences between fungi and humans. Firstly, most human phosphate homeostasis disturbances relate to failure to sufficiently excrete excess phosphate, e.g., in renal insufficiency (except during starvation or in rare genetic conditions) [91]. This is because we inevitably acquire substantial amounts of phosphate with the plant- or animal-based foods that provide enough protein. Secondly, human phosphate transporters must function in conditions of neutral or mildly alkaline pH, while in fungi, a proton-phosphate symporter whose optimum is acidic is the most efficient transporter. This proton-phosphate symporter in C. albicans is Pho84 and it has no human homolog. In the basidiomycete pathogen Cryptococcus neoformans, virulence is attenuated when the 3 high-affinity Pi transporters at the cell surface are mutated [92]. Given the essentiality of phosphate in cellular functions, it is striking that C. albicans has not evolved more redundancy for Pho84 activity: among at least 3 others, loss of this single plasma membrane phosphate importer is sufficient to affect virulence [75].
An efficient inhibitor of Pho84 hence not only may directly slow growth by diminishing phosphate supplies of the fungal cell and by inhibiting TORC1 signaling, but could also block oxidative stress management, attenuating virulence. Furthermore, by depleting the cell of substrates for cell wall biosynthetic enzymes, it could weaken the cell wall and potentiate the activity of drugs that inhibit these enzymes.
Much remains to be discovered in how Candida cells regulate the acquisition and distribution of phosphate. Recent exciting work in other fungi implicates inositol pyrophosphates in regulating elements of the PHO regulon through N-terminal SPX domains of these proteins [93]. Delineating differences between S. cerevisiae and Candida PHO regulons will shed further light on the specific phosphate-related requirements of a human commensal and opportunist. The role of ATP depletion in multiple virulence-related cellular processes awaits further analysis. The finding that pho84 null cells’ walls contain less of the polysaccharides whose synthesis requires nucleotide sugar substrates, raises the question how the cell allocates scarce phosphate supplies to each cellular process. Does it prioritize translation over cell wall construction? Along the path of these coming discoveries, novel drug targets are likely to appear given the difference of fungal and human cellular phosphate management. As more fungal pathogens like Candida auris emerge, more questions will arise. Some of the answers may contribute to medical advances.

Funding

This work was funded by National Institute of Allergy and Infectious Diseases (R21AI137716 and R21AI141189), and by Boston Children’s Hospital Department of Pediatrics. M.A.-Z. was partially funded by the Alfonso Martin Escudero Foundation.

Acknowledgments

We thank Tahmeena Chowdhury, Jumei Zheng, Ning-Ning Liu, and Joann Diray-Arce for thoughtful discussions.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Ikeh, M.; Ahmed, Y.; Quinn, J. Phosphate Acquisition and Virulence in Human Fungal Pathogens. Microorganisms 2017, 5, 48. [Google Scholar] [CrossRef] [PubMed]
  2. Lev, S.; Djordjevic, J.T. Why is a functional PHO pathway required by fungal pathogens to disseminate within a phosphate-rich host: A paradox explained by alkaline pH-simulated nutrient deprivation and expanded PHO pathway function. PLoS Pathog. 2018, 14. [Google Scholar] [CrossRef] [PubMed]
  3. Cohen, R.; Roth, F.J.; Delgado, E.; Ahearn, D.G.; Kalser, M.H. Fungal flora of the normal human small and large intestine. N. Engl. J. Med. 1969, 280, 638–641. [Google Scholar] [CrossRef] [PubMed]
  4. Arendorf, T.M.; Walker, D.M. The prevalence and intra-oral distribution of Candida albicans in man. Arch. Oral Biol. 1980, 25, 1–10. [Google Scholar] [CrossRef]
  5. Ghannoum, M.A.; Jurevic, R.J.; Mukherjee, P.K.; Cui, F.; Sikaroodi, M.; Naqvi, A.; Gillevet, P.M. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 2010, 6. [Google Scholar] [CrossRef] [Green Version]
  6. Odds, F.C.; Brown, A.J.; Gow, N.A. Candida albicans genome sequence: A platform for genomics in the absence of genetics. Genome Biol. 2004, 5, 230. [Google Scholar] [CrossRef] [Green Version]
  7. Bensasson, D.; Dicks, J.; Ludwig, J.M.; Bond, C.J.; Elliston, A.; Roberts, I.N.; James, S.A. Diverse Lineages of Candida albicans Live on Old Oaks. Genetics 2019, 211, 277–288. [Google Scholar] [CrossRef] [Green Version]
  8. Angebault, C.; Djossou, F.; Abelanet, S.; Permal, E.; Ben Soltana, M.; Diancourt, L.; Bouchier, C.; Woerther, P.-L.; Catzeflis, F.; Andremont, A.; et al. Candida albicans is not always the preferential yeast colonizing humans: A study in Wayampi Amerindians. J. Infect. Dis. 2013, 208, 1705–1716. [Google Scholar] [CrossRef] [Green Version]
  9. Moyes, D.L.; Wilson, D.; Richardson, J.P.; Mogavero, S.; Tang, S.X.; Wernecke, J.; Höfs, S.; Gratacap, R.L.; Robbins, J.; Runglall, M.; et al. Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature 2016, 532, 64–68. [Google Scholar] [CrossRef] [Green Version]
  10. Jennison, R.F. Thrush in infancy. Arch. Dis. Child. 1977, 52, 747–749. [Google Scholar] [CrossRef] [Green Version]
  11. Johnson, S.A. Candida (Monilia) albicans: Effect of amino acids, glucose, pH, chlortetracycline (aureomycin), dibasic sodium and calcium phosphates, and anaerobic and aerobic conditions on its growth. AMA Arch. Dermatol. Syphilol. 1954, 70, 49–60. [Google Scholar] [CrossRef] [PubMed]
  12. Brown, A.J.; Budge, S.; Kaloriti, D.; Tillmann, A.; Jacobsen, M.D.; Yin, Z.; Ene, I.V.; Bohovych, I.; Sandai, D.; Kastora, S.; et al. Stress adaptation in a pathogenic fungus. J. Exp. Biol. 2014, 217, 144–155. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Ferreira, G.C.; Pedersen, P.L. Phosphate transport in mitochondria: Past accomplishments, present problems, and future challenges. J. Bioenerg. Biomembr. 1993, 25, 483–492. [Google Scholar] [CrossRef] [PubMed]
  14. Zara, V.; Dietmeier, K.; Palmisano, A.; Vozza, A.; Rassow, J.; Palmieri, F.; Pfanner, N. Yeast mitochondria lacking the phosphate carrier/p32 are blocked in phosphate transport but can import preproteins after regeneration of a membrane potential. Mol. Cell. Biol. 1996, 16, 6524–6531. [Google Scholar] [CrossRef] [Green Version]
  15. Liu, N.N.; Flanagan, P.R.; Zeng, J.; Jani, N.M.; Cardenas, M.E.; Moran, G.P.; Köhler, J.R. Phosphate is the third nutrient monitored by TOR in Candida albicans and provides a target for fungal-specific indirect TOR inhibition. Proc. Natl. Acad. Sci. USA 2017. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Santos-Beneit, F. The Pho regulon: A huge regulatory network in bacteria. Front. Microbiol. 2015, 6, 402. [Google Scholar] [CrossRef] [Green Version]
  17. Tamai, Y.; Toh-e, A.; Oshima, Y. Regulation of inorganic phosphate transport systems in Saccharomyces cerevisiae. J. Bacteriol. 1985, 164, 964–968. [Google Scholar] [CrossRef] [Green Version]
  18. Lenburg, M.E.; O’Shea, E.K. Signaling phosphate starvation. Trends Biochem. Sci. 1996, 21, 383–387. [Google Scholar] [CrossRef]
  19. Persson, B.L.; Lagerstedt, J.O.; Pratt, J.R.; Pattison-Granberg, J.; Lundh, K.; Shokrollahzadeh, S.; Lundh, F. Regulation of phosphate acquisition in Saccharomyces cerevisiae. Curr. Genet. 2003, 43, 225–244. [Google Scholar] [CrossRef] [PubMed]
  20. Lamarche, M.G.; Wanner, B.L.; Crepin, S.; Harel, J. The phosphate regulon and bacterial virulence: A regulatory network connecting phosphate homeostasis and pathogenesis. FEMS Microbiol. Rev. 2008, 32, 461–473. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Chekabab, S.M.; Harel, J.; Dozois, C.M. Interplay between genetic regulation of phosphate homeostasis and bacterial virulence. Virulence 2014, 5, 786–793. [Google Scholar] [CrossRef] [Green Version]
  22. Chekabab, S.M.; Jubelin, G.; Dozois, C.M.; Harel, J. PhoB activates Escherichia coli O157:H7 virulence factors in response to inorganic phosphate limitation. PLoS ONE 2014, 9. [Google Scholar] [CrossRef]
  23. Tomar, P.; Sinha, H. Conservation of PHO pathway in ascomycetes and the role of Pho84. J. Biosci. 2014, 39, 525–536. [Google Scholar] [CrossRef] [PubMed]
  24. MacCallum, D.M.; Castillo, L.; Nather, K.; Munro, C.A.; Brown, A.J.; Gow, N.A.; Odds, F.C. Property differences among the four major Candida albicans strain clades. Eukaryot. Cell 2009, 8, 373–387. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Skrzypek, M.S.; Binkley, J.; Binkley, G.; Miyasato, S.R.; Simison, M.; Sherlock, G. The Candida Genome Database (CGD): Incorporation of Assembly 22, systematic identifiers and visualization of high throughput sequencing data. Nucleic Acids Res. 2017, 45, D592–D596. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Fradin, C.; De Groot, P.; MacCallum, D.; Schaller, M.; Klis, F.; Odds, F.C. Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol. Microbiol. 2005, 56, 397–415. [Google Scholar] [CrossRef]
  27. Thewes, S.; Kretschmar, M.; Park, H.; Schaller, M.; Filler, S.G.; Hube, B. In vivo and ex vivo comparative transcriptional profiling of invasive and non-invasive Candida albicans isolates identifies genes associated with tissue invasion. Mol. Microbiol. 2007, 63, 1606–1628. [Google Scholar] [CrossRef]
  28. Zakikhany, K.; Naglik, J.R.; Schmidt-Westhausen, A.; Holland, G.; Schaller, M.; Hube, B. In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination. Cell. Microbiol. 2007, 9, 2938–2954. [Google Scholar] [CrossRef]
  29. Walker, L.A.; Maccallum, D.M.; Bertram, G.; Gow, N.A.; Odds, F.C.; Brown, A.J. Genome-wide analysis of Candida albicans gene expression patterns during infection of the mammalian kidney. Fungal Genet. Biol. 2009, 46, 210–219. [Google Scholar] [CrossRef] [Green Version]
  30. Hebecker, B.; Vlaic, S.; Conrad, T.; Bauer, M.; Brunke, S.; Kapitan, M.; Kapitan, M.; Hube, B.; Jacobsen, I.D. Dual-species transcriptional profiling during systemic candidiasis reveals organ-specific host-pathogen interactions. Sci. Rep. 2016, 6, 36055. [Google Scholar] [CrossRef] [Green Version]
  31. Munoz, J.F.; Delorey, T.; Ford, C.B.; Li, B.Y.; Thompson, D.A.; Rao, R.P.; Cuomo, C.A. Coordinated host-pathogen transcriptional dynamics revealed using sorted subpopulations and single macrophages infected with Candida albicans. Nat. Commun. 2019, 10, 1607. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Urrialde, V.; Prieto, D.; Pla, J.; Alonso-Monge, R. The Candida albicans Pho4 Transcription Factor Mediates Susceptibility to Stress and Influences Fitness in a Mouse Commensalism Model. Front. Microbiol. 2016, 7, 1062. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Ikeh, M.A.; Kastora, S.L.; Day, A.M.; Herrero-de-Dios, C.M.; Tarrant, E.; Waldron, K.J.; Banks, A.P.; Bain, J.M.; Lydall, D.; Veal, E.A.; et al. Pho4 mediates phosphate acquisition in Candida albicans and is vital for stress resistance and metal homeostasis. Mol. Biol. Cell 2016. [Google Scholar] [CrossRef]
  34. Homann, O.R.; Dea, J.; Noble, S.M.; Johnson, A.D. A phenotypic profile of the Candida albicans regulatory network. PLoS Genet. 2009, 5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Vandeputte, P.; Pradervand, S.; Ischer, F.; Coste, A.T.; Ferrari, S.; Harshman, K.; Sanglard, D. Identification and functional characterization of Rca1, a transcription factor involved in both antifungal susceptibility and host response in Candida albicans. Eukaryot. Cell 2012, 11, 916–931. [Google Scholar] [CrossRef] [Green Version]
  36. Urrialde, V.; Prieto, D.; Pla, J.; Alonso-Monge, R. The Pho4 transcription factor mediates the response to arsenate and arsenite in Candida albicans. Front. Microbiol. 2015, 6, 118. [Google Scholar] [CrossRef] [Green Version]
  37. Urrialde, V.; Alburquerque, B.; Guirao-Abad, J.P.; Pla, J.; Arguelles, J.C.; Alonso-Monge, R. Arsenic inorganic compounds cause oxidative stress mediated by the transcription factor PHO4 in Candida albicans. Microbiol. Res. 2017, 203, 10–18. [Google Scholar] [CrossRef]
  38. Ogawa, N.; DeRisi, J.; Brown, P.O. New components of a system for phosphate accumulation and polyphosphate metabolism in Saccharomyces cerevisiae revealed by genomic expression analysis. Mol. Biol. Cell 2000, 11, 4309–4321. [Google Scholar] [CrossRef] [Green Version]
  39. Orkwis, B.R.; Davies, D.L.; Kerwin, C.L.; Sanglard, D.; Wykoff, D.D. Novel acid phosphatase in Candida glabrata suggests selective pressure and niche specialization in the phosphate signal transduction pathway. Genetics 2010, 186, 85–95. [Google Scholar] [CrossRef] [Green Version]
  40. Li, C.X.; Gleason, J.E.; Zhang, S.X.; Bruno, V.M.; Cormack, B.P.; Culotta, V.C. Candida albicans adapts to host copper during infection by swapping metal cofactors for superoxide dismutase. Proc. Natl. Acad. Sci. USA 2015, 112, E5336–E5342. [Google Scholar] [CrossRef] [Green Version]
  41. Fidel, P.L.; Vazquez, J.A.; Sobel, J.D. Candida glabrata: Review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev. 1999, 12, 80–96. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Kerwin, C.L.; Wykoff, D.D. Candida glabrata PHO4 is necessary and sufficient for Pho2-independent transcription of phosphate starvation genes. Genetics 2009, 182, 471–479. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Mortimer, R.; Polsinelli, M. On the origins of wine yeast. Res. Microbiol. 1999, 150, 199–204. [Google Scholar] [CrossRef]
  44. Zhou, X.; O’Shea, E.K. Integrated approaches reveal determinants of genome-wide binding and function of the transcription factor Pho4. Mol. Cell 2011, 42, 826–836. [Google Scholar] [CrossRef] [Green Version]
  45. He, B.Z.; Zhou, X.; O’Shea, E.K. Evolution of reduced co-activator dependence led to target expansion of a starvation response pathway. eLife 2017, 6. [Google Scholar] [CrossRef] [Green Version]
  46. Daignan-Fornier, B.; Fink, G.R. Coregulation of purine and histidine biosynthesis by the transcriptional activators BAS1 and BAS2. Proc. Natl. Acad. Sci. USA 1992, 89, 6746–6750. [Google Scholar] [CrossRef] [Green Version]
  47. Brown, A.J.P.; Gow, N.A.R.; Warris, A.; Brown, G.D. Memory in Fungal Pathogens Promotes Immune Evasion, Colonisation, and Infection. Trends Microbiol. 2019, 27, 219–230. [Google Scholar] [CrossRef] [Green Version]
  48. Rebora, K.; Desmoucelles, C.; Borne, F.; Pinson, B.; Daignan-Fornier, B. Yeast AMP pathway genes respond to adenine through regulated synthesis of a metabolic intermediate. Mol. Cell. Biol. 2001, 21, 7901–7912. [Google Scholar] [CrossRef] [Green Version]
  49. Gauthier, S.; Coulpier, F.; Jourdren, L.; Merle, M.; Beck, S.; Konrad, M.; Daignan-Fornier, B.; Pinson, B. Co-regulation of yeast purine and phosphate pathways in response to adenylic nucleotide variations. Mol. Microbiol. 2008, 68, 1583–1594. [Google Scholar] [CrossRef]
  50. Ghosh, A.K.; Wangsanut, T.; Fonzi, W.A.; Rolfes, R.J. The GRF10 homeobox gene regulates filamentous growth in the human fungal pathogen Candida albicans. FEMS Yeast Res. 2015, 15. [Google Scholar] [CrossRef] [Green Version]
  51. Wangsanut, T.; Ghosh, A.K.; Metzger, P.G.; Fonzi, W.A.; Rolfes, R.J. Grf10 and Bas1 Regulate Transcription of Adenylate and One-Carbon Biosynthesis Genes and Affect Virulence in the Human Fungal Pathogen Candida albicans. mSphere 2017, 2. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. David, L.N.; Michael, M. Princples of Biochemistry, 7th ed.; Macmillan Learning: New York, NY, USA, 2017. [Google Scholar]
  53. Bishop, A.C.; Sun, T.; Johnson, M.E.; Bruno, V.M.; Patton-Vogt, J. Robust utilization of phospholipase-generated metabolites, glycerophosphodiesters, by Candida albicans: Role of the CaGit1 permease. Eukaryot. Cell 2011, 10, 1618–1627. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Bishop, A.C.; Ganguly, S.; Solis, N.V.; Cooley, B.M.; Jensen-Seaman, M.I.; Filler, S.G.; Mitchell, A.P.; Patton-Vogt, J. Glycerophosphocholine utilization by Candida albicans: Role of the Git3 transporter in virulence. J. Biol. Chem. 2013, 288, 33939–33952. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Samyn, D.R.; Ruiz-Pavon, L.; Andersson, M.R.; Popova, Y.; Thevelein, J.M.; Persson, B.L. Mutational analysis of putative phosphate- and proton-binding sites in the Saccharomyces cerevisiae Pho84 phosphate: H(+) transceptor and its effect on signalling to the PKA and PHO pathways. Biochem. J. 2012, 445, 413–422. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Serrano, R.; Ruiz, A.; Bernal, D.; Chambers, J.R.; Arino, J. The transcriptional response to alkaline pH in Saccharomyces cerevisiae: Evidence for calcium-mediated signalling. Mol. Microbiol. 2002, 46, 1319–1333. [Google Scholar] [CrossRef] [PubMed]
  57. Inglis, D.O.; Arnaud, M.B.; Binkley, J.; Shah, P.; Skrzypek, M.S.; Wymore, F.; Binkley, G.; Miyasato, S.R.; Simison, M.; Sherlock, G. The Candida genome database incorporates multiple Candida species: Multispecies search and analysis tools with curated gene and protein information for Candida albicans and Candida glabrata. Nucleic Acids Res. 2012, 40, D667–D674. [Google Scholar] [CrossRef]
  58. Giots, F.; Donaton, M.C.; Thevelein, J.M. Inorganic phosphate is sensed by specific phosphate carriers and acts in concert with glucose as a nutrient signal for activation of the protein kinase A pathway in the yeast Saccharomyces cerevisiae. Mol. Microbiol. 2003, 47, 1163–1181. [Google Scholar] [CrossRef] [PubMed]
  59. Popova, Y.; Thayumanavan, P.; Lonati, E.; Agrochao, M.; Thevelein, J.M. Transport and signaling through the phosphate-binding site of the yeast Pho84 phosphate transceptor. Proc. Natl. Acad. Sci. USA 2010, 107, 2890–2895. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. Schothorst, J.; Kankipati, H.N.; Conrad, M.; Samyn, D.R.; Van Zeebroeck, G.; Popova, Y.; Rubio-Texeira, M.; Persson, B.L.; Thevelein, J.M. Yeast nutrient transceptors provide novel insight in the functionality of membrane transporters. Curr. Genet. 2013, 59, 197–206. [Google Scholar] [CrossRef] [Green Version]
  61. Mouillon, J.M.; Persson, B.L. New aspects on phosphate sensing and signalling in Saccharomyces cerevisiae. FEMS Yeast Res. 2006, 6, 171–176. [Google Scholar] [CrossRef] [Green Version]
  62. Barbet, N.C.; Schneider, U.; Helliwell, S.B.; Stansfield, I.; Tuite, M.F.; Hall, M.N. TOR controls translation initiation and early G1 progression in yeast. Mol. Biol. Cell 1996, 7, 25–42. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Loewith, R.; Hall, M.N. Target of rapamycin (TOR) in nutrient signaling and growth control. Genetics 2011, 189, 1177–1201. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Stracka, D.; Jozefczuk, S.; Rudroff, F.; Sauer, U.; Hall, M.N. Nitrogen source activates TOR (target of rapamycin) complex 1 via glutamine and independently of Gtr/Rag proteins. J. Biol. Chem. 2014, 289, 25010–25020. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Gonzalez, A.; Hall, M.N. Nutrient sensing and TOR signaling in yeast and mammals. EMBO J. 2017, 36, 397–408. [Google Scholar] [CrossRef] [Green Version]
  66. Chowdhury, T.; Köhler, J.R. Ribosomal protein S6 phosphorylation is controlled by TOR and modulated by PKA in Candida albicans. Mol. Microbiol. 2015, 98, 384–402. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Ljungdahl, P.O.; Daignan-Fornier, B. Regulation of amino acid, nucleotide, and phosphate metabolism in Saccharomyces cerevisiae. Genetics 2012, 190, 885–929. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  68. Boeckstaens, M.; Llinares, E.; Van Vooren, P.; Marini, A.M. The TORC1 effector kinase Npr1 fine tunes the inherent activity of the Mep2 ammonium transport protein. Nat. Commun. 2014, 5, 3101. [Google Scholar] [CrossRef] [Green Version]
  69. Bastidas, R.J.; Heitman, J.; Cardenas, M.E. The protein kinase Tor1 regulates adhesin gene expression in Candida albicans. PLoS Pathog. 2009, 5. [Google Scholar] [CrossRef] [Green Version]
  70. Cutler, N.S.; Pan, X.; Heitman, J.; Cardenas, M.E. The TOR signal transduction cascade controls cellular differentiation in response to nutrients. Mol. Biol. Cell 2001, 12, 4103–4113. [Google Scholar] [CrossRef] [Green Version]
  71. Sehgal, S.N.; Baker, H.; Vezina, C. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. J. Antibiot. 1975, 28, 727–732. [Google Scholar] [CrossRef] [Green Version]
  72. Baker, H.; Sidorowicz, A.; Sehgal, S.N.; Vezina, C. Rapamycin (AY-22,989), a new antifungal antibiotic. III. In vitro and in vivo evaluation. J. Antibiot. 1978, 31, 539–545. [Google Scholar] [CrossRef] [PubMed]
  73. Martel, R.R.; Klicius, J.; Galet, S. Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can. J. Physiol. Pharmacol. 1977, 55, 48–51. [Google Scholar] [CrossRef] [PubMed]
  74. Kaplan, B.; Qazi, Y.; Wellen, J.R. Strategies for the management of adverse events associated with mTOR inhibitors. Transplant. Rev. 2014, 28, 126–133. [Google Scholar] [CrossRef] [Green Version]
  75. Liu, N.N.; Uppuluri, P.; Broggi, A.; Besold, A.; Ryman, K.; Kambara, H.; Solis, N.; Lorenz, V.; Qi, W.; Acosta-Zaldívar, M.; et al. Intersection of phosphate transport, oxidative stress and TOR signalling in Candida albicans virulence. PLoS Pathog. 2018, 14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Gray, M.J.; Jakob, U. Oxidative stress protection by polyphosphate--new roles for an old player. Curr. Opin. Microbiol. 2015, 24, 1–6. [Google Scholar] [CrossRef] [Green Version]
  77. Hothorn, M.; Neumann, H.; Lenherr, E.D.; Wehner, M.; Rybin, V.; Hassa, P.O.; Uttenweiler, A.; Reinhardt, M.; Schmidt, A.; Seiler, J.; et al. Catalytic core of a membrane-associated eukaryotic polyphosphate polymerase. Science 2009, 324, 513–516. [Google Scholar] [CrossRef]
  78. Gerasimaite, R.; Sharma, S.; Desfougeres, Y.; Schmidt, A.; Mayer, A. Coupled synthesis and translocation restrains polyphosphate to acidocalcisome-like vacuoles and prevents its toxicity. J. Cell Sci. 2014, 127, 5093–5104. [Google Scholar] [CrossRef] [Green Version]
  79. Broxton, C.N.; Culotta, V.C. SOD Enzymes and Microbial Pathogens: Surviving the Oxidative Storm of Infection. PLoS Pathog. 2016, 12. [Google Scholar] [CrossRef] [Green Version]
  80. Liu, N.-N.; Acosta-Zaldívar, M.; Qi, W.; Diray-Arce, J.; Walker, L.; Kottom, T.J.; Kelly, R.; Yuan, M.; Asara, J.M.; Lasky-Su, J.A.; et al. Phosphoric metabolites link phosphate import and polysaccharide biosynthesis for Candida albicans cell wall maintenance. mBio 2020, 11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  81. Sheshachalam, A.; Srivastava, N.; Mitchell, T.; Lacy, P.; Eitzen, G. Granule protein processing and regulated secretion in neutrophils. Front. Immunol. 2014, 5, 448. [Google Scholar] [CrossRef] [Green Version]
  82. Han, Q.; Wang, N.; Yao, G.; Mu, C.; Wang, Y.; Sang, J. Blocking beta-1,6-glucan synthesis by deleting KRE6 and SKN1 attenuates the virulence of Candida albicans. Mol. Microbiol. 2018. [Google Scholar] [CrossRef]
  83. Bushby, S.R.; Hitchings, G.H. Trimethoprim, a sulphonamide potentiator. Br. J. Pharmacol. Chemother. 1968, 33, 72–90. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. McLellan, C.A.; Vincent, B.M.; Solis, N.V.; Lancaster, A.K.; Sullivan, L.B.; Hartland, C.L.; Youngsaye, W.; Filler, S.G.; Whitesell, L.; Lindquist, S. Inhibiting mitochondrial phosphate transport as an unexploited antifungal strategy. Nat. Chem. Biol. 2018, 14, 135–141. [Google Scholar] [CrossRef] [PubMed]
  85. Leonardi, R.; Zhang, Y.M.; Rock, C.O.; Jackowski, S. Coenzyme A: Back in action. Prog. Lipid Res. 2005, 44, 125–153. [Google Scholar] [CrossRef]
  86. Kowalska, E.; Kujda, M.; Wolak, N.; Kozik, A. Altered expression and activities of enzymes involved in thiamine diphosphate biosynthesis in Saccharomyces cerevisiae under oxidative and osmotic stress. FEMS Yeast Res. 2012, 12, 534–546. [Google Scholar] [CrossRef] [Green Version]
  87. Huh, W.K.; Lee, B.H.; Kim, S.T.; Kim, Y.R.; Rhie, G.E.; Baek, Y.W.; Hwang, C.S.; Lee, J.S.; Kang, S.O. D-Erythroascorbic acid is an important antioxidant molecule in Saccharomyces cerevisiae. Mol. Microbiol. 1998, 30, 895–903. [Google Scholar] [CrossRef]
  88. Jung, I.L.; Kim, I.G. Thiamine protects against paraquat-induced damage: Scavenging activity of reactive oxygen species. Environ. Toxicol. Pharmacol. 2003, 15, 19–26. [Google Scholar] [CrossRef]
  89. Wolak, N.; Kowalska, E.; Kozik, A.; Rapala-Kozik, M. Thiamine increases the resistance of baker’s yeast Saccharomyces cerevisiae against oxidative, osmotic and thermal stress, through mechanisms partly independent of thiamine diphosphate-bound enzymes. FEMS Yeast Res. 2014, 14, 1249–1262. [Google Scholar] [CrossRef] [Green Version]
  90. Huh, W.K.; Kim, S.T.; Kim, H.; Jeong, G.; Kang, S.O. Deficiency of D-erythroascorbic acid attenuates hyphal growth and virulence of Candida albicans. Infect. Immun. 2001, 69, 3939–3946. [Google Scholar] [CrossRef] [Green Version]
  91. Schiavi, S.C.; Kumar, R. The phosphatonin pathway: New insights in phosphate homeostasis. Kidney Int. 2004, 65, 1–14. [Google Scholar] [CrossRef] [Green Version]
  92. Kretschmer, M.; Reiner, E.; Hu, G.; Tam, N.; Oliveira, D.L.; Caza, M.; Yeon, J.H.; Kim, J.; Kastrup, C.J.; Jung, W.H.; et al. Defects in phosphate acquisition and storage influence virulence of Cryptococcus neoformans. Infect. Immun. 2014, 82, 2697–2712. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Wild, R.; Gerasimaite, R.; Jung, J.Y.; Truffault, V.; Pavlovic, I.; Schmidt, A.; Saiardi, A.; Jessen, H.J.; Poirier, Y.; Hothorn, M.; et al. Control of eukaryotic phosphate homeostasis by inositol polyphosphate sensor domains. Science 2016, 352, 986–990. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Model: Candida albicans phosphate (Pi) homeostasis maintenance. Under limited Pi conditions, Pi is imported by high-affinity transporters Pho84 and Pho89 whose pH optimum is in the acidic and alkaline range, respectively. Decreased Pi availability also activates the PHO regulon, whose central transcription factor Pho4 is dephosphorylated and localized to the nucleus. Independent of the interaction with the Pho2 homolog Grf10, Pho4 alone activates the expression of genes to maintain intracellular Pi homeostasis, including high-affinity Pi transporters (PHO84 and PHO89), polyphosphate synthesis complex (VTC1–4), glycerophosphodiester transporters (GIT1–3), glycerophosphocholine phosphodiesterase (GDE1), as well as acid phosphatases (PHO100, 112, and 113).
Figure 1. Model: Candida albicans phosphate (Pi) homeostasis maintenance. Under limited Pi conditions, Pi is imported by high-affinity transporters Pho84 and Pho89 whose pH optimum is in the acidic and alkaline range, respectively. Decreased Pi availability also activates the PHO regulon, whose central transcription factor Pho4 is dephosphorylated and localized to the nucleus. Independent of the interaction with the Pho2 homolog Grf10, Pho4 alone activates the expression of genes to maintain intracellular Pi homeostasis, including high-affinity Pi transporters (PHO84 and PHO89), polyphosphate synthesis complex (VTC1–4), glycerophosphodiester transporters (GIT1–3), glycerophosphocholine phosphodiesterase (GDE1), as well as acid phosphatases (PHO100, 112, and 113).
Jof 06 00040 g001
Figure 2. Model: Pho84 contributes to C. albicans TORC1 signaling, metabolism, cell wall integrity and oxidative stress defense. The high-affinity inorganic phosphate (Pi) transporter Pho84 plays a significant role in cellular import of Pi. Cytosolic and mitochondrial Pi becomes available to metabolic processes that produce substrates for cell wall construction enzymes (nucleotide sugars UDP-glucose and UDP-N-Acetylglucosamine, GlcNAc), the energy currency ATP, and co-factors with possible roles in detoxifying reactive oxygen species (ROS), i.e., thiamine pyrophosphate and erythro-ascorbic acid. Pho84 also contributes to oxidative stress management by activating TORC1 through Gtr1. TORC1 induces the expression of superoxide dismutase Sod3, contributing to C. albicans tolerance of ROS produced by host immune cells.
Figure 2. Model: Pho84 contributes to C. albicans TORC1 signaling, metabolism, cell wall integrity and oxidative stress defense. The high-affinity inorganic phosphate (Pi) transporter Pho84 plays a significant role in cellular import of Pi. Cytosolic and mitochondrial Pi becomes available to metabolic processes that produce substrates for cell wall construction enzymes (nucleotide sugars UDP-glucose and UDP-N-Acetylglucosamine, GlcNAc), the energy currency ATP, and co-factors with possible roles in detoxifying reactive oxygen species (ROS), i.e., thiamine pyrophosphate and erythro-ascorbic acid. Pho84 also contributes to oxidative stress management by activating TORC1 through Gtr1. TORC1 induces the expression of superoxide dismutase Sod3, contributing to C. albicans tolerance of ROS produced by host immune cells.
Jof 06 00040 g002

Share and Cite

MDPI and ACS Style

Köhler, J.R.; Acosta-Zaldívar, M.; Qi, W. Phosphate in Virulence of Candida albicans and Candida glabrata. J. Fungi 2020, 6, 40. https://doi.org/10.3390/jof6020040

AMA Style

Köhler JR, Acosta-Zaldívar M, Qi W. Phosphate in Virulence of Candida albicans and Candida glabrata. Journal of Fungi. 2020; 6(2):40. https://doi.org/10.3390/jof6020040

Chicago/Turabian Style

Köhler, Julia R., Maikel Acosta-Zaldívar, and Wanjun Qi. 2020. "Phosphate in Virulence of Candida albicans and Candida glabrata" Journal of Fungi 6, no. 2: 40. https://doi.org/10.3390/jof6020040

APA Style

Köhler, J. R., Acosta-Zaldívar, M., & Qi, W. (2020). Phosphate in Virulence of Candida albicans and Candida glabrata. Journal of Fungi, 6(2), 40. https://doi.org/10.3390/jof6020040

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop